共 90 条
[1]
Hosp C(2017)Safety of available and emerging drug therapies for hyperhidrosis Expert Opin Drug Saf. 16 1039-1049
[2]
Hamm H(2004)US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey J Am Acad Dermatol. 51 241-248
[3]
Strutton DR(2019)Topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis: Results from the ATMOS-1 and ATMOS-2 phase 3 randomized controlled trials J Am Acad Dermatol 80 128-138
[4]
Kowalski JW(2017)The impact of hyperhidrosis on patients' daily life and quality of life: a qualitative investigation Health Qual Life Outcomes. 15 121-568
[5]
Glaser DA(2006)Impact of patient-reported outcome measures on routine practice: a structured review J Eval Clin Pract. 12 559-S4S5
[6]
Stang PE(2018)Hyperhidrosis and its impact on those living with it Am J Manag Care. 24 S491-308
[7]
Glaser DA(2019)Hyperhidrosis quality of life measures: review and patient perspective J Dermatolog Treat. 30 303-1027
[8]
Hebert AA(2015)The development and validation of a disease-specific quality of life measure in hyperhidrosis: the Hyperhidrosis Quality of Life Index (HidroQOL(c)) Qual Life Res. 24 1017-92
[9]
Nast A(2018)A taxonomy has been developed for outcomes in medical research to help improve knowledge discovery J Clin Epidemiol. 96 84-1157
[10]
Werschler WP(2015)Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation BMJ. 350 g7647-843